文献速递遗传性与小管间质肾病肾小球疾病

Cystin-1肉豆蔻酰-静电开关破坏导致类ARPKD多囊肾病

Disruption of the human cystin-1 myristoyl-electrostatic switch causes polycystic kidney disease that phenocopies autosomal recessive polycystic kidney disease.
PubMed 文献 · Kidney Int · 2026-02-18

本研究通过两个家系发现CYS1致病变异(大片段缺失和p.Gly2Ser)导致类ARPKD多囊肾,并揭示cystin-1的肉豆蔻酰-静电开关调控其膜结合与纤毛运输。

要点

  • CYS1双等位基因致病变异可导致类ARPKD多囊肾病。
  • cystin-1的N端肉豆蔻酰-静电开关调控其可逆膜结合。
  • S17磷酸化调节cystin-1的膜关联和细胞内运输。

核心结论

  • Cystin-1的细胞内运输和功能受肉豆蔻酰-静电开关机制调控。
  • 三个CYS1纯合致病变异个体中的囊性肾病支持cystin-1缺陷导致类ARPKD多囊肾病。

研究设计与样本

  • 研究利用高分辨率超声、阵列比较基因组杂交和外显子测序在两个家系中鉴定类ARPKD肾病变和CYS1缺陷。
  • 通过生物信息学分析比较哺乳动物cystin序列保守性,并采用免疫荧光、光遗传学和3D培养评估野生型和突变型cystin的亚细胞定位、纤毛运输和囊肿形成。
  • 使用串联亲和纯化/质谱鉴定cystin结合伙伴,并功能评估S17磷酸化。

主要发现

  • 家系1先证者携带约24-kb纯合缺失,涵盖CYS1调控区和外显子1。
  • 家系2两名受累同胞携带纯合CYS1 c.4G>A (p.Gly2Ser)变异,影响N端肉豆蔻酰化基序中的Gly2。
  • 该区域与邻近的富含精氨酸片段(侧翼为S8和S17)构成保守的肉豆蔻酰-静电开关,可调控可逆的蛋白-膜结合。
  • S17磷酸化调节cystin膜关联和细胞内运输。
  • 在3D培养中,CRISPR/Cas9生成的cystin缺失细胞或表达cystin-1G2S的缺失细胞与各自对照相比显示增强的囊肿形成。

临床怎么用

  • 对于类ARPKD表型且PKHD1阴性的患者,应考虑CYS1基因检测。
  • cystin-1的肉豆蔻酰-静电开关机制可能为多囊肾病提供潜在治疗靶点。

局限性

  • 研究基于两个家系和体外/离体实验,样本量有限。
  • CYS1变异导致类ARPKD的机制尚未在体内模型中完全验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Autosomal recessive polycystic kidney disease (ARPKD) is caused primarily by pathogenic variants in PKHD1, encoding fibrocystin/polyductin. In Cys1cpk/cpk (cpk) mice, the kidney and liver lesions closely phenocopy ARPKD. Cys1 encodes cystin, a myristoylated protein that traffics to the primary cilium and nucleus. We recently reported the first patient with ARPKD due to a homozygous CYS1 splicing variant. METHODS: To study this, we utilized high-resolution ultrasound, array Comparative Genomic Hybridization and exon sequencing to identify an ARPKD-like kidney lesion and CYS1 defects in two families. Bioinformatic analyses compared cystin sequence conservation across mammals. Immunofluorescence, optogenetic studies, and 3D culture comparatively evaluated subcellular localization, ciliary trafficking, and cyst formation under cAMP stimulation of wild-type and mutant cystin. Tandem affinity purification/mass spectrometry identified cystin-binding partners. Serine-17 phosphorylation was evaluated functionally. RESULTS: The Family 1 proband carried a homozygous deletion about 24-kb in size encompassing the CYS1 regulatory region and exon 1. In Family 2, two affected siblings had a homozygous CYS1 c.4G>A (p.Gly2Ser) variant affecting Gly2 within the N-terminal myristoylation motif. This region, together with an adjacent arginine-rich stretch flanked by serines-8 (S8) and -17 (S17) residues, comprises a conserved myristoyl-electrostatic switch that can regulate reversible protein-membrane binding. S17 phosphorylation modulates cystin membrane association and intracellular trafficking. In 3D culture, CRISPR/Cas9-generated cystin-null cells or null cells expressing cystin-1G2S showed enhanced cyst formation versus their respective controls. cAMP activation by cilia-specific optogenetic stimulation in cultured cells or pharmacologic treatment of ex vivo embryonic kidneys reduced cystin ciliary localization in a protein kinase A-dependent manner. Mass spectrometry identified the phosphatase PPM1A as a cystin-interacting partner, and pharmacologic inhibition reduced cystin S17 dephosphorylation. CONCLUSIONS: Cystin-1 intracellular trafficking and function are regulated by a myristoyl-electrostatic switch mechanism. Cystic kidneys in three individuals with homozygous CYS1 pathogenic variants provide further support that cystin-1 deficiency causes polycystic kidney disease that phenocopies ARPKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Yang C, Harafuji N, Watts JA, et al. Disruption of the human cystin-1 myristoyl-electrostatic switch causes polycystic kidney disease that phenocopies autosomal recessive polycystic kidney disease. Kidney Int. 2026. PMID: 41720266. doi:10.1016/j.kint.2026.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。